公司簡介

金字塔心腦血管生物科技有限公司，由Danny Lee臨床專家創立，是一家在加拿大關於研究動脈粥樣硬化, 涉及心腦血管疾病防治、研發生產；天然草本植物生物製劑健康產品。

公司總部位於氣候宜人，風景優美的加拿大溫哥華。公司集健康科普、咨詢、講座、研發與生產於一體的高科技公司。創辦人Danny Lee臨床家20多年來“勤求古訓，博采眾長”。其理念是急則治標，緩則治本，未病先防、既病防變、康了防復；長期致力於高血壓（沉默殺手）、高脂血症（隱形殺手）、高血糖（隱形殺手）、高尿酸（沉默殺手）；簡稱“四高”共同都存在心腦血管疾病併發症的病理學研究。

《靈樞•九針十二原》曰：“疾雖久,猶可畢也.言不可治者，未得其術也”。產品依據臨床驗方，研發思路切入廣度和深度，學貫中西，大膽創新，突破盲點，另辟蹊徑，尋求其本。探索疑難病症防治，繼往開來，師古不泥，推陳出新，結合運用現代科研成果，也只有這樣傳統中醫學才能與時代同步，而自強於世界醫學之林。

Danny Lee臨床家，曾13年時間台北往來南京中醫藥大學，研究學習傳統中醫學及現代醫學各科理論與臨床。研究學習期間得到諸多知名研究生導師，國醫大師言傳親授。有位博生士導師則根據Danny Lee臨床家天資好學；預言鼓勵將來通過努力，應該可以成為醫學家。一位臨床教授口頭言：“血管年輕，人就年輕，人與血管同壽”，受益匪淺。先後還參與編輯出版10多種醫學書籍，其中《補益中藥與臨床驗方》擔任副主編工作。長達13年的學醫生涯“猶如十年磨一劍”，為研究有所悟之；打下了扎實理論與臨床功底。

Company Profile

Pyramid Cardiovascular and Cerebral Vascular Biotechnology Co., Ltd., founded by clinical expert Danny Lee, is a Canadian company focusing on the research of atherosclerosis, prevention and treatment of cardiovascular and cerebrovascular diseases, R&D and production, and a natural herbal biologics health products company.

The company is headquartered in Vancouver, Canada, which has a pleasant climate and beautiful scenery. The company is a high-tech company integrating health science popularization, consultation, lectures, R&D and production. The founder, clinician Danny Lee, has been "diligently seeking ancient teachings and learning from the best of others" for more than 20 years. Its philosophy is to treat the symptoms when it is urgent, and treat the root cause when it is slow, to prevent the disease before it occurs, to prevent the disease from becoming worse, and to prevent its recovery after recovery; it has long been committed to hypertension (silent killer), hyperlipidemia (invisible killer), and hyperglycemia (invisible killer). ), high uric acid (silent hand); referred to as the "four highs" all have pathological research on cardiovascular and cerebrovascular disease complications.

"Lingshu·Nine Needles and Twelve Origins" says: "Although the disease lasts for a long time, it can still be cured. If it is said that it cannot be cured, it has not been cured." The products are based on clinical prescriptions, and the research and development ideas are broad and deep. They learn from both Chinese and Western medicine, boldly innovate, break through blind spots, find new ways, and seek their roots. Exploring the prevention and treatment of difficult diseases, carrying forward the past and forging ahead into the future, learning from the past, innovating with the old, and combining the results of modern scientific research with the application of modern scientific research results. Only in this way can traditional Chinese medicine keep pace with the times and become stronger in the world of medicine.

Danny Lee, a clinician, has been traveling to Nanjing University of Chinese Medicine in Taipei for 13 years, studying the theories and clinical practices of traditional Chinese medicine and modern medicine. During the research and study period, I received many well-known graduate tutors and personal teachings from masters of traditional Chinese medicine. A doctoral supervisor, based on Danny Lee's clinical talent and eagerness to learn, predicted that through hard work, he should be able to become a medical scientist in the future. A clinical professor said: "When blood vessels are young, people are young, and people live as long as blood vessels." He has benefited a lot. He has also participated in the editing and publishing of more than 10 medical books, including "Tonic Chinese Medicine and Clinical Prescriptions" as deputy editor-in-chief. The 13-year medical career is "like ten years of sharpening a sword", which has provided me with insights for research and laid a solid theoretical and clinical foundation.